Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-31 4:57 pm Purchase | 2025-03-27 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT LLC | 15,016,063 24.800% | 34,445 (+0.23%) | Filing History |
| 2024-02-14 08:32 am Sale | 2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital, LP | 0 0.000% | -3,952,000 (Position Closed) | Filing History |
| 2024-02-06 09:02 am Purchase | 2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | FRANKLIN RESOURCES INC BEN | 3,358,809 5.800% | 3,358,809 (New Position) | Filing History |
| 2024-01-24 4:22 pm Purchase | 2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | MURRAY JAMES B JR | 2,681,057 4.600% | 100,000 (+3.87%) | Filing History |
| 2023-07-25 4:31 pm Purchase | 2023-07-21 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT LLC | 14,981,618 25.900% | 5,207,067 (+53.27%) | Filing History |
| 2023-02-14 4:24 pm Sale | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Manning Paul B | 3,205,128 7.800% | -805,550 (-20.09%) | Filing History |
| 2023-02-14 3:25 pm Purchase | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Sands Capital Ventures LLC | 3,417,075 8.300% | 3,417,075 (New Position) | Filing History |
| 2023-02-14 08:21 am Purchase | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital, LP | 3,952,000 9.660% | 1,537,083 (+63.65%) | Filing History |
| 2022-10-07 2:58 pm Sale | 2022-09-30 | 13G | Acumen Pharmaceuticals, Inc. ABOS | BlackRock Inc. BLK | 1,115,027 2.800% | -1,994,643 (-64.14%) | Filing History |
| 2022-02-16 4:25 pm Purchase | 2021-07-01 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Hardie Molly G. | 3,451,152 8.500% | 3,451,152 (New Position) | Filing History |
| 2022-02-14 7:27 pm Purchase | 2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Manning Paul B | 4,010,678 9.900% | 4,010,678 (New Position) | Filing History |
| 2022-02-14 4:03 pm Purchase | 2021-07-06 | 13G | Acumen Pharmaceuticals, Inc. ABOS | MURRAY JAMES B JR | 2,581,057 6.400% | 2,581,057 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | BlackRock Inc. BLK | 3,109,670 7.700% | 3,109,670 (New Position) | Filing History |
| 2022-01-27 4:34 pm Purchase | 2022-01-24 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Capital, LP | 2,414,917 5.970% | 2,414,917 (New Position) | Filing History |
| 2021-09-13 4:30 pm Purchase | 2021-09-10 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT LLC | 9,774,551 24.200% | 3,778 (+0.04%) | Filing History |
| 2021-07-16 4:30 pm Purchase | 2021-07-06 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA CAPITAL MANAGEMENT LLC | 9,770,773 25.300% | 9,770,773 (New Position) | Filing History |
| 2021-07-12 9:08 pm Purchase | 2021-07-06 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Sands Capital Ventures Discovery Fund III L.P. | 3,417,075 8.840% | 3,417,075 (New Position) | Filing History |